Shawn Tomasello Insider Trading $KITE Kite Pharma, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Shawn Tomasello.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Shawn Tomasello. Shawn Tomasello is Director in ABEONA THERAPEUTICS INC. ($AKC) and Chief Commercial Officer in PHARMACYCLICS INC ($PCYC) and Chief Commercial Officer in Kite Pharma, Inc. ($KITE) and Director in Principia Biopharma Inc. ($PRNB) and Director in Diplomat Pharmacy, Inc. ($DPLO) and Director in 4D Molecular Therapeutics Inc. ($FDMT) and Director in UroGen Pharma Ltd. ($URGN) and Director in TCR2 THERAPEUTICS INC. ($TCRR).
Shawn Tomasello in Kite Pharma, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Shawn Tomasello: Chief Commercial Officer
Holdings: 56,068 shares
Current Value: $2,989,546
Latest Transaction: Oct 05 2017
$KITE Market Capitalization: $2.64B
$KITE Previous Close: $53.32
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Shawn Tomasello in Kite Pharma, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, FDMT, AKC, DPLO, KITE, PCYC, PRNB, TCRR, URGN
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 05 2017 | KITE | Kite Pharma, Inc. | Tomasello Shawn | Chief Commercial Of ... | Option Exercise | D | 46.09 | 38,500 | 1,774,465 | 0 | |
| Oct 05 2017 | KITE | Kite Pharma, Inc. | Tomasello Shawn | Chief Commercial Of ... | Option Exercise | D | 63.87 | 67,000 | 4,279,290 | 0 | |
| Oct 05 2017 | KITE | Kite Pharma, Inc. | Tomasello Shawn | Chief Commercial Of ... | Option Exercise | D | 63.87 | 93,000 | 5,939,910 | 0 | |
| Oct 05 2017 | KITE | Kite Pharma, Inc. | Tomasello Shawn | Chief Commercial Of ... | Sell | D | 0.00 | 39,933 | 0 | 0 | 39.9 K to 0 (-100.00 %) |
| Oct 05 2017 | KITE | Kite Pharma, Inc. | Tomasello Shawn | Chief Commercial Of ... | Sell | U | 180.00 | 16,135 | 2,904,300 | 39,933 | 56.1 K to 39.9 K (-28.78 %) |
| Oct 05 2017 | KITE | Kite Pharma, Inc. | Tomasello Shawn | Chief Commercial Of ... | Gift | G | 0.00 | 5,000 | 0 | 56,068 | 61.1 K to 56.1 K (-8.19 %) |
| Sep 27 2017 | KITE | Kite Pharma, Inc. | Tomasello Shawn | Chief Commercial Of ... | Sell | S | 179.66 | 4,203 | 755,127 | 61,068 | 65.3 K to 61.1 K (-6.44 %) |
| Sep 27 2017 | KITE | Kite Pharma, Inc. | Tomasello Shawn | Chief Commercial Of ... | Grant | A | 0.00 | 4,500 | 0 | 65,271 | 60.8 K to 65.3 K (+7.40 %) |
| Dec 27 2016 | KITE | Kite Pharma, Inc. | Tomasello Shawn | Chief Commercial Of ... | Option Exercise | A | 46.09 | 38,500 | 1,774,465 | 38,500 | |
| Dec 27 2016 | KITE | Kite Pharma, Inc. | Tomasello Shawn | Chief Commercial Of ... | Grant | A | 0.00 | 10,600 | 0 | 60,235 | 49.6 K to 60.2 K (+21.36 %) |
| Dec 22 2016 | KITE | Kite Pharma, Inc. | Tomasello Shawn | Chief Commercial Of ... | Sell | S | 50.86 | 4,901 | 249,265 | 49,635 | 54.5 K to 49.6 K (-8.99 %) |
| Dec 21 2015 | KITE | Kite Pharma, Inc. | Tomasello Shawn | Chief Commercial Of ... | Option Exercise | A | 63.87 | 160,000 | 10,219,200 | 160,000 | |
| Dec 21 2015 | KITE | Kite Pharma, Inc. | Tomasello Shawn | Chief Commercial Of ... | Grant | A | 0.00 | 44,000 | 0 | 54,000 | 10 K to 54 K (+440.00 %) |
Page: 1